CLINICAL_TRIALS
trial_result
· 2010-06-29
Clinical Trial Update: V501 Efficacy Study in Women Aged 18 to 26 (V501-027) [Phase 2]
Summary
A Phase 2 efficacy study (V501-027) of an HPV vaccine in women aged 18 to 26 completed, with results posted in 2010-06-29.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: HPV Infections | Phase 2 | Status: COMPLETED | Results posted: 2010-06-29